Concerns over Champix

caution warning danger sign
Potential contamination of varenicline medicines being investigated by the TGA as batch recall begins The Therapeutic Goods Administraion (TGA) says it is investigating potential contamination of varenicline medicines with the nitrosamine impurity, N-nitrosovarenicline. The regulator says it "has been advised that very low levels of the N-nitrosovarenicline have been detected in Australian varenicline products". As

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous PPE plays ‘mitigating role’, but not only factor
Next ‘How much did doctors’ lobbying influence the initial shape of the rollout?’